Search results with tag "Relapsed"
BC Cancer Protocol Summary for Treatment of Relapsed ...
www.bccancer.bc.caBC Cancer Protocol Summary for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Using iBRUtinib Protocol Code ULYIBRU Tumour Group Lymphoma Contact Physician Dr. Laurie Sehn . ELIGIBILITY
Emerging Treatment Options for Relapsed and Refractory ...
www.hematologyandoncology.netEmerging Treatment Options for Relapsed and Refractory Multiple Myeloma Abstract: Multiple myeloma is a major hematologic malignancy, with an incidence of over 20,000 new diagnoses
Quick Reference Guide - MRSA Topical Eradication
www.swagcanceralliance.nhs.ukRelapsed/refractory CLL and low grade lymphoma in patients unsuitable for other treatment options. Omit rituximab if CD20 negative. (Rituximab NICE TA243) ICD-10 codes Codes with a prefix C82, C83, C85 and C91 Regimen details Day Drug Dose Route 0 or 1 Rituximab* 375mg/m2 IV infusion 1 Doxorubicin 50mg/m2 IV bolus
NSSG Chemotherapy Protocol - NSSG - Haematology
nssg.oxford-haematology.org.ukRelapsed or Refractory Lymphoma, for patients unsuitable for R-GDP regimen. Omit rituximab if CD20- negative TREATMENT INTENT Disease modification PRE-ASSESSMENT 1. Ensure histology is confirmed prior to administration of chemotherapy and document in notes. 2. Record stage and IPI of disease - CT scan (neck, chest, abdomen and pelvis), and/or ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.novartis.usAdult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). (1.3) Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy. (1.4)
TIP: Paclitaxel / Ifosfamide / Cisplatin in Relapsed …
www.londoncanceralliance.nhs.ukReason for Update: Network Protocol Development Approved by Gynaecology Consultant: Ana Montes Version: 1.1 Approved by Urology Consultant: Hartmut Kristeleit
GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for ...
www.londoncanceralliance.nhs.ukGEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for relapsed / refractory Lymphoma Page 1 of 4 Reason for Update: Network Protocol Development Approved by Consultant: P Fields 29/03/2012 Version: 1 Approved by Chair Haem TWG: Majid Kazmi
Gem-Cisp: Gemcitabine/Cisplatin in Relapsed Ovarian ...
www.londoncanceralliance.nhs.ukReason for Update: Network Protocol Development Gemcitabine. should be used with caution in patients with impaired renal function: CrCl (ml/min) Gemcitabine Dose
BC Cancer Protocol Summary for Treatment of Philadelphia ...
www.bccancer.bc.caAdult patients with Ph-positive or Ph-negative pre-B cell acute lymphoblastic leukemia (ALL) Relapsed or refractory after at least oneof the followings: Refractory to induction or to salvage chemotherapy Relapse within 12 months of first remission (CR1)
MULTIPLE MYELOMA (MM) - Celgene
media.celgene.comArea of Research Phase 1 Phase 2 Phase 3 Post-Approval Research C C F P- esear C- C- T T appr LYMPHOMA REVLIMID® (lenalidomide) Mantle cell lymphoma: Relapsed/refractory . . . . . . . . . . Diffuse large B-cell lymphoma (ABC subtype): First-line .
Similar queries
Relapsed, Relapsed/Refractory Chronic Lymphocytic Leukemia or, Lymphocytic, Emerging Treatment Options for Relapsed and Refractory, Emerging Treatment Options for Relapsed and Refractory Multiple Myeloma, Multiple myeloma, Refractory, Negative, PRESCRIBING INFORMATION, GEMOX +/-R Gemcitabine, Oxaliplatin +/- Rituximab, GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for relapsed / refractory, Negative pre, Celgene